600 patients66,869 observations120 daysLIVE

Patient P-01407

Synthetic patientNBL-101 · Day 108 · 65–74 · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 31 NP-02 recommendedDietary Support Protocol NP-02
  3. Day 32 Patient acceptedStarted NP-02 in the companion
  4. Day 42 No meaningful changeDietary Support Protocol NP-02
  5. Day 48 Trajectory diverged from predictionObserved response fell below the model's expected path.
  6. Day 52 GI-04 recommendedGI Support Protocol GI-04
  7. Day 53 Patient declinedNot now

What changed?

Trajectory began diverging from predicted response on Day 48.

Primary contributors, last 14 days
  • Toxicity+10
  • GI instability+9
  • Nutritional resilience-8
  • Treatment adherence-4
  • Inflammatory activity+2

What helped?

  • Dietary Support Protocol NP-02Day 31
    Result: no meaningful change
  • GI Support Protocol GI-04Day 52
    Declined by patient
LIFE OS recommendation
GI Support Protocol GI-04
92%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
77/100
worsening · +13.7 vs previous 14 d
Toxicity
Blood
56.6/100
worsening · +3.6 vs previous 14 d
Sleep quality
Wearable
8.6/100
worsening · -5.6 vs previous 14 d
Energy level
Daily log
1.2/10
worsening · -0.8 vs previous 14 d
Stress level
Daily log
7.8/10
worsening · +0.6 vs previous 14 d
Steps
Wearable
395
worsening · -458 vs previous 14 d
Adherence
Companion
40.6 %
stable · -0.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 23 from the failing basin, 82 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 97%
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 79%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 79%
Would not help
  • NP-02 Dietary Support Protocol
    already tried, no meaningful change
  • Keep fat low
    GI +4.7 next day on high-intake days · n 21
  • Keep fibre low
    GI +3.7 next day on high-intake days · n 18
  • Keep simple carbs low
    GI +3 next day on high-intake days · n 19
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +4.7detractor · 95%
  • Insoluble fibre
    +3.7detractor · 94%
  • Alcohol
    +3.2no signal · 54%
  • Simple carbohydrates
    +3detractor · 84%
  • Spicy / capsaicin
    +1.4no signal · 34%
  • Histamine load
    -0.7no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Autonomic recovery 65
    • WearableResting HR 74 bpm
    • Wearable395 steps/day
    • WearableShort sleep window
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 77 and rising
    • WearableSleep 5.2 h, below personal baseline
  • Inflammatory signalling 60
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 67
    • WearableHRV 20 ms, trending down
  • Drug metabolism and exposure 60
    • DNACYP2D6 poor metabolizer → higher exposure
    • BloodToxicity index 57
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 30/100
    • Daily logFibre intake low in recent food logs
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 2.4 · butyrate capacity 30/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
25 ms
Sleep
5.5 h
Steps
962
Resting HR
75 bpm
Daily log: GI score 77, nutritional resilience 29, adherence 41.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0138616%S1370
P-0135216%S2070
P-0169921%S04GI-04improved69
P-0150817%S1868
P-0150917%S1768
P-0181717%S1467
P-0187722%S01CR-01improved67
P-0151516%S1666
P-0162917%S1966
P-0171419%S14GI-04improved66
P-0185825%S14NP-02improved65
P-0131717%S1965